Literature DB >> 27059483

Integration of Chinese medicine with Western medicine could lead to future medicine: molecular module medicine.

Chi Zhang1, Ge Zhang1, Ke-ji Chen2, Ai-ping Lu3.   

Abstract

The development of an effective classification method for human health conditions is essential for precise diagnosis and delivery of tailored therapy to individuals. Contemporary classification of disease systems has properties that limit its information content and usability. Chinese medicine pattern classification has been incorporated with disease classification, and this integrated classification method became more precise because of the increased understanding of the molecular mechanisms. However, we are still facing the complexity of diseases and patterns in the classification of health conditions. With continuing advances in omics methodologies and instrumentation, we are proposing a new classification approach: molecular module classification, which is applying molecular modules to classifying human health status. The initiative would be precisely defining the health status, providing accurate diagnoses, optimizing the therapeutics and improving new drug discovery strategy. Therefore, there would be no current disease diagnosis, no disease pattern classification, and in the future, a new medicine based on this classification, molecular module medicine, could redefine health statuses and reshape the clinical practice.

Entities:  

Keywords:  Chinese medicine pattern classification; classification of disease; methodology; molecular module medicine

Mesh:

Year:  2016        PMID: 27059483     DOI: 10.1007/s11655-016-2495-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  65 in total

Review 1.  Network biology: understanding the cell's functional organization.

Authors:  Albert-László Barabási; Zoltán N Oltvai
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

Review 2.  Systems biology in drug discovery.

Authors:  Eugene C Butcher; Ellen L Berg; Eric J Kunkel
Journal:  Nat Biotechnol       Date:  2004-10       Impact factor: 54.908

Review 3.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

4.  Drug-target network.

Authors:  Muhammed A Yildirim; Kwang-Il Goh; Michael E Cusick; Albert-László Barabási; Marc Vidal
Journal:  Nat Biotechnol       Date:  2007-10       Impact factor: 54.908

5.  Error in medicine.

Authors:  L L Leape
Journal:  JAMA       Date:  1994-12-21       Impact factor: 56.272

6.  Drug Repurposing from an Academic Perspective.

Authors:  Tudor I Oprea; Julie E Bauman; Cristian G Bologa; Tione Buranda; Alexandre Chigaev; Bruce S Edwards; Jonathan W Jarvik; Hattie D Gresham; Mark K Haynes; Brian Hjelle; Robert Hromas; Laurie Hudson; Debra A Mackenzie; Carolyn Y Muller; John C Reed; Peter C Simons; Yelena Smagley; Juan Strouse; Zurab Surviladze; Todd Thompson; Oleg Ursu; Anna Waller; Angela Wandinger-Ness; Stuart S Winter; Yang Wu; Susan M Young; Richard S Larson; Cheryl Willman; Larry A Sklar
Journal:  Drug Discov Today Ther Strateg       Date:  2011

Review 7.  Application of genomics, proteomics and metabolomics in drug discovery, development and clinic.

Authors:  Craig Russell; Ayesha Rahman; Afzal R Mohammed
Journal:  Ther Deliv       Date:  2013-03

Review 8.  Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

Authors:  Emanuel F Petricoin; Verena E Bichsel; Valerie S Calvert; Virginia Espina; Mary Winters; Lynn Young; Claudio Belluco; Bruce J Trock; Marc Lippman; David A Fishman; Dennis C Sgroi; Peter J Munson; Laura J Esserman; Lance A Liotta
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

Review 9.  Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group.

Authors:  S Shak
Journal:  Semin Oncol       Date:  1999-08       Impact factor: 4.929

10.  A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.

Authors:  Jeremy A Miller; Michael C Oldham; Daniel H Geschwind
Journal:  J Neurosci       Date:  2008-02-06       Impact factor: 6.167

View more
  1 in total

1.  Network Intervention, a Method to Address Complex Therapeutic Strategies.

Authors:  Chi Zhang; Wei Zhou; Dao-Gang Guan; Yong-Hua Wang; Ai-Ping Lu
Journal:  Front Pharmacol       Date:  2018-07-12       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.